Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Go back to Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)| (NASDAQ: JAGX) | Delayed: 1.05 -0.28 (21.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $4.60 | |||
| Open | $1.33 | 52 Week Low | $0.81 | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $0.97 | EPS | $0.00 | |||
| Volume | 199,032 | |||||
